IC
Ikarian Capital Portfolio holdings
AUM
$773M
1-Year Est. Return
443.74%
This Fund
S&P 500
1 Year Est. Return
+443.74%
AUM
$773M
AUM Growth
+$278M
(+56%)
Holding
181
Top Buys
| 1 | +$33.1M | |
| 2 | +$14.6M | |
| 3 | +$14.3M | |
| 4 |
Olema Pharmaceuticals
OLMA
|
+$13.5M |
| 5 |
Eli Lilly
LLY
|
+$13.2M |
Top Sells
| 1 | +$53M | |
| 2 | +$20.7M | |
| 3 | +$16M | |
| 4 |
Dianthus Therapeutics
DNTH
|
+$13.6M |
| 5 |
PTC Therapeutics
PTCT
|
+$11.8M |
Sector Composition
| 1 | Healthcare | 99.47% |
| 2 | Financials | 0.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
iBio
IBIO
$97.8M
| $1.85M | 0.24% |
957,062
+339,735
|
|
||
77
Apellis Pharmaceuticals
APLS
$2.54B
| $1.8M | 0.23% |
71,747
-380,155
|
|
||
|
SLN
78
Silence Therapeutics
SLN
$268M
| $1.73M | 0.22% |
865,784
-35,000
|
|
||
79
Verastem
VSTM
$438M
| $1.65M | 0.21% |
+213,865
|
|
||
80
Insmed
INSM
$31.7B
| $1.63M | 0.21% |
9,337
-4,414
|
|
||
81
NewAmsterdam Pharma
NAMS
$3.5B
| $1.61M | 0.21% |
45,830
-60,970
|
|
||
82
Lipocine
LPCN
$46.7M
| $1.6M | 0.21% |
+199,542
|
|
||
83
Surrozen
SRZN
$230M
| $1.49M | 0.19% |
+65,788
|
|
||
84
Wave Life Sciences
WVE
$2.5B
| $1.45M | 0.19% |
85,285
-10,670
|
|
||
85
Catalyst Pharmaceutical
CPRX
$2.94B
| $1.34M | 0.17% |
57,388
-59,000
|
|
||
86
Lyell Immunopharma
LYEL
$496M
| $1.26M | 0.16% |
41,081
-2,718
|
|
||
87
Annexon
ANNX
$833M
| $1.16M | 0.15% |
+230,244
|
|
||
|
HELP
88
Cybin Inc
HELP
$426M
| $1.08M | 0.14% |
132,153
-8,322
|
|
||
89
Neuronetics
STIM
$87M
| $968K | 0.13% |
701,182
-204,534
|
|
||
90
Solid Biosciences
SLDB
$464M
| $905K | 0.12% |
160,409
-16,281
|
|
||
91
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$74.9M
| $860K | 0.11% |
40,822
-51,137
|
|
||
92
IO Biotech
IOBT
$23.9M
| $844K | 0.11% |
1,386,565
-139,328
|
|
||
|
DFTX
93
Definium Therapeutics
DFTX
$1.74B
| $787K | 0.1% |
58,803
-3,888
|
|
||
94
Traws Pharma
TRAW
$13.2M
| $766K | 0.1% |
678,142
+649,649
|
|
||
95
Palisade Bio
PALI
$252M
| $646K | 0.08% |
+274,978
|
|
||
96
Kezar Life Sciences
KZR
$52M
| $643K | 0.08% |
102,211
-4,690
|
|
||
97
KalVista Pharmaceuticals
KALV
$827M
| $567K | 0.07% |
+35,119
|
|
||
98
Avalo Therapeutics
AVTX
$349M
| $565K | 0.07% |
31,106
-128,671
|
|
||
99
Acumen Pharmaceuticals
ABOS
$200M
| $537K | 0.07% |
254,312
-11,457
|
|
||
100
Sangamo Therapeutics
SGMO
$147M
| $512K | 0.07% |
1,218,671
-75,981
|
|